Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease

Microbes and Infection

Volumn 9, Issue 1, 2007, Pages 15-20

  Moens, Leen ^a   Verhaegen, Jan ^a   Pierik, Marie ^a   Vermeire, Severine ^a   De Boeck, Kris ^a   Peetermans, Willy E ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Invasive pneumococcal infection; Polymorphisms; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; MUTANT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; POLYMORPHISM, GENETIC; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 33846487358     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.10.002     Document Type: Article

References (43)

1. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
2. Janssens S., and Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 16 4 (2003) 637-646
3. Takeda K., and Akira S. Microbial recognition by Toll-like receptors. J. Dermatol. Sci. 34 (2004) 73-82
4. Echchannaoui H., Frei K., Schnell C., Leib S.L., Zimmerli W., and Landmann R. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 186 (2002) 798-806
5. Koedel U., Angele B., Rupprecht T., Wagner H., Roggenkamp A., Phister H., et al. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170 (2003) 438-444
6. Khan A.Q., Chen Q., Wu Z.-Q., Paton J., and Snapper C.M. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on Toll-like receptor 2. Infect. Immun. 73 1 (2005) 298-307
7. Knapp S., Wieland C.W., van't Veer C., Takeuchi O., Akira S., Florquin S., et al. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J. Immunol. 172 (2004) 3132-3138
8. Branger J., Knapp S., Weijer S., Leemans J.C., Pater J.M., Speelman P., et al. Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect. Immun. 72 2 (2004) 788-794
9. Malley R., Henneke P., Morse S.C., Cieslewicz M.J., Lipsitch M., Thompson C.M., et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. PNAS 100 4 (2003) 1966-1971
10. Yoshimura A., Lien E., Ingalls R.R., Toumanen E., Dziarski R., and Golenbock D. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163 (1999) 1-5
11. Cook D.N., Pisetsky D.S., and Schwartz D.A. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5 10 (2004) 975-979
12. Lorenz E., Mira J., Cornish K.L., Arbour N.C., and Schwartz D.A. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68 11 (2000) 6398-6401
13. Ogus A.C., Yoldas B., Ozdemir T., Uguz A., Olcen S., Keser I., et al. The Arg753GLn polymorphism of the human Toll-like receptor 2 gene and tuberculosis disease. Eur. Respir. J. 23 2 (2004) 219-223
14. Kang T., and Chae G. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol. 31 (2001) 53-58
15. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., et al. Tlr4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25 (2000) 187-191
16. Schwartz D.A. The role of TLR4 in endotoxin responsiveness in humans. J. Endotoxin Res. 7 5 (2001) 389-393
17. Lorenz E., Mira J., Frees K., and Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram negative septic shock. Arch. Intern. Med. 162 (2002) 1028-1032
18. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., et al. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186 (2002) 1522-1525
19. Hawn T.R., Verbon A., Janer M., Zhao L.P., Beutler B., and Aderem A. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. PNAS 102 7 (2005) 2487-2489
20. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonaroa E., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347 3 (2002) 185-192
21. Read R.C., Pullin J., Gregory S., Borrow R., Kaczmarski E.B., di Giovine F.S., et al. A functional polymorphism of Toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis. 184 (2001) 640-642
22. Sánchez E., Orozco G., López-Nevot M.A., Jiménez-Alonso J., and Martín J. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 63 (2004) 54-57
23. Rozen S., and Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology (2000), Humana Press, Totowa, NJ 365-386. http://fokker.wi.mit.edu/primer3/ Source code available at:
24. Lorenz E., Frees J.K., and Schwartz D.A. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques 31 (2001) 22-24
25. Bogaert D., de Groot R., and Hermans P.W.M. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet 4 (2004) 144-154
26. Schröder N.W.J., and Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5 (2005) 156-164
27. Roy S., Hill A.V.S., Griffiths D., and Crook D. Association of common genetic variant with susceptibility to invasive pneumococcal disease. BMJ 324 (2002) 1369
28. Ambrosino D.M., Schiffman G., Gotschlich E.C., Schur P.H., Rosenberg G.A., DeLange G.G., et al. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J. Clin. Invest. 75 (1985) 1935-1942
29. Chapman S.J., Khor C.C., Vannberg F.O., Maskell N.A., Davies C.W.H., Hedley E.L., et al. PTPN22 and invasive bacterial disease. Nat. Genet. 38 5 (2006) 499-500
30. van Sorge N.M., van der Pol W.-L., and van de Winkel J.G.J. FcγR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61 (2003) 189-202
31. Moens L., Van Hoeyveld E., Verhaegen J., De Boeck K., Peetermans W.E., and Bossuyt X. Fcgamma-receptor IIA genotype and invasive pneumococcal infection. Clin. Immunol. 118 1 (2006) 20-23
32. Roy S., Knox K., Segal S., Griffiths D., Moore C.E., Welsh K.I., Smarason A., Day N.P., McPheat W.L., Crook D.W., Hill A.V.S., and The Oxford Pneumococcal Surveillance Group. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359 (2002) 1569-1573
33. Schwartz D.A. The genetics of innate immunity. Chest 121 3 (2002) 62S-68S
34. Schröder N.W.J., Hermann C., Hamann, Göbel U.B., Hartung T., and Schumann R.R. High frequency of polymorphism Arg753Glu, of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J. Mol. Med. 81 (2003) 368-372
35. Renshaw M., Rockwell J., Engleman C., Gewirtz A., Katz J., and Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J. Immunol. 169 (2002) 4697-4701
36. Lauener R.P., Birchler T., Adamski J., Braun-Fahrlander C., Bufe A., Herz U., von Mutius E., Nowak D., Riedler J., Waser M., and Sennhauser F.H. Experssion of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 360 (2002) 465-466
37. Hamann L., Gomma A., Schröder N.W.J., Stamme C., Glaeser C., Schulz S., Gross M., Anker S.D., Fox K., and Schumann R.R. A frequent Toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J. Mol. Med. 83 (2005) 478-485
38. Montes A.H., Asensi V., Alvarez V., Valle E., Ocaña M.G., Meana A., et al. The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for gram-negative and haematogenous osteomyelitis. Clini. Exp. Immunol. 143 (2006) 404-413
39. van den Graaf C., Kullberg B.J., Joosten L., Verver-Jansen T., Jacobs L., Van der Meer J., et al. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine 30 (2005) 264-268
40. von Aulock S., Schröder N.W.J., Traub S., Gueinzius K., Lorenz E., Hartung T., et al. Heterozygous Toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses. Infect. Immun. 72 3 (2004) 1828-1831
41. Lanoue A., Clatworthy M.R., Smith P., Green S., Townsend M.J., Jolin H.E., Smith K.G., Fallon P.G., and McKenzie A.N. SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J. Exp. Med. 200 11 (2004) 1383-1393
42. Carsetti R., Rosado M.M., Donnanno S., Guazzi V., Soresina A., Meini A., Plebani A., Aiuti F., and Quinti I. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol. 115 (2005) 412-417
43. Brown J.S., Hussell T., Gilliland S.M., Holden D.W., Paton J.C., Ehrenstein M.R., Walport M.J., and Botto M. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. PNAS 99 26 (2002) 16969-16974